The reduction in revenues due to the decline in COVID-19-related products and services is expected to diminish or disappear in 2025. Thermo Fisher has been growing by acquiring other companies.

During the pandemic, spending on diagnostics and vaccine research skyrocketed, and one of the main beneficiaries was Thermo Fisher, as its catalog of products and services aligned perfectly with ...

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twenty-two brokerages that are currently covering the stock, ...